IP Library Granted Patent US 10,614,909
Granted Patent B2
US 10,614,909 · App. 15/017,453 · Granted Apr 7, 2020

Quantum mechanical/X-ray crystallography diagnostic for proteins

Inventors: Lance Michael Westerhoff (Annville, PA); Oleh Y. Borbulevych (Bellefonte, PA); Roger Isaac Martin (State College, PA)
Assignee: QuantumBio Inc.
G16B15/00G01N23/20008G01N33/6803G16B20/00G01N2223/304G01N2223/612
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,614,909
App. No.
15/017,453
Granted
Apr 7, 2020
Kind
B2
Abstract

An analytic method for improving the efficiency in identifying protein molecular effect information using low resolution x-ray crystallography, by selecting and imaging a protein sample with low resolution x-ray crystallography and assaying the data thus generated as to local ligand strain energy value, followed by calculating a real-space difference density Z for each element and compiling ZDD data therefrom, followed by determining the true protomer/tautomer state of the protein sample by calculating Score i according to the following equation so that the highest Score i signifies the molecuar effect information: Score i ={((ZDD i −μ ZDD )/σ ZDD )+((SE i −μ SE )/σ SE )}.

Claims (6)

1. An analytic method more efficiently to identify conformational, protonation, or solvent effect information from a real world protein of interest by using low resolution x-ray crystallography, comprising the steps of: a) selecting an aliquot of a real world protein sample as a protein to be diagnosed; b) imaging said protein by low resolution x-ray crystallography and collecting a quantity of crystallography data generated thereby; c) assaying x-ray density within said crystallography data and creating from said crystallography data thus assayed a population set containing a plurality of set elements consisting of all or reasonably all possible protomer/tautomer states of said real world protein; d) determining a local ligand strain energy value SE for each of said elements; e) determining ZDD for each of said elements by calculating a real-space difference density Z for each element and compiling ZDD data therefrom; and f) selecting a single element from among said elements that represents the true protomer/tautomer state of at least one moiety of said protein by calculating Score i according to the following equation,

Score i ={((ZDD i −μ ZDD )/σ ZDD )+((SE i −μ SE )/σ SE )}

wherein the highest Score, obtained for said population corresponds to the best tautomeric form “i” that fits both SE and ZDD criteria, so that Score, when output to a user identifies the element from said population that most closely corresponds with said real world protein thus diagnosed with increased time efficiency using said low resolution x-ray crystallography compared to the same method using atomic resolution x-ray crystallography.

2. An analytic method to identify conformational, protonation, or solvent effect information from a real world protein of interest by using low resolution x-ray crystallography having a maximum resolution of 1.1 angstrom, comprising the steps of: a) selecting an aliquot of a real world protein sample as a protein to be diagnosed; b) imaging said protein by x-ray crystallography having a maximum resolution of 1.1 angstrom and collecting a quantity of crystallography data generated thereby; c) assaying x-ray density within said crystallography data and creating from said crystallography data thus assayed a population set containing a plurality of set elements consisting of all or reasonably all possible protomer/tautomer states of said real world protein; d) determining a local ligand strain energy value SE for each of said elements; e) determining ZDD for each of said elements by calculating a real-space difference density Z for each element and compiling ZDD data therefrom; and f) selecting a single element from among said elements that represents the true protomer/tautomer state of at least one moiety of said protein by calculating Score i according to the following equation,

Score i ={((ZDD i −μ ZDD )/σ ZDD )+((SE i −μ SE )/σ SE )}

wherein the highest Score, obtained for said population corresponds to the best tautomeric form “i” that fits both SE and ZDD criteria, so that Score, when output to a user identifies—with increased time efficiency using said low resolution x-ray crystallography compared to the same method using atomic resolution x-ray crystallography—an element from said population that most closely corresponds with said real world protein.

Assignments (2)
CONFIRMATORY LICENSE Recorded Nov 21, 2022
From: QUANTUMBIO INC
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 061974/0878 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2016
From: BORBULEVYCH, OLEH Y; MARTIN, ROGER ISAAC; WESTERHOFF, LANCE MICHAEL
To: QUANTUMBIO INC.
Reel/Frame 037685/0096 →
Continuity (4)
Provisional Application 62157787 · May 6, 2015
Provisional Application 62112951 · Feb 6, 2015
Related Publication 20170228495A1 · Aug 10, 2017
Related Publication 20190026421A9 · Jan 24, 2019
Cited By (1)
US 12,347,524